Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: Relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise

Journal of Rheumatology

Volumn 32, Issue 4, 2005, Pages 729-733

  Alsufyani, Khayriah A ^a   Ortiz Alvarez, Olivia ^a   Cabral, David A ^b   Tucker, Lori B ^a   Petty, Ross E ^a   Nadel, Helen ^b   Malleson, Peter N ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Bone density; Child; Corticosteroids; Juvenile dermatomyositis; Osteoporosis; Systemic lupus erythematosus; Systemic vasculitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ASIAN; BONE DENSITY; BONE MINERALIZATION; CALCIUM INTAKE; CALCULATION; CANADA; CAUCASIAN; CONFIDENCE INTERVAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; DEMOGRAPHY; DERMATOMYOSITIS; DISEASE DURATION; DRUG DOSE REGIMEN; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; DYNAMIC EXERCISE; FEMALE; HIP; HUMAN; INDIAN; JUVENILE DERMATOMYOSITIS; LUMBAR SPINE; MALE; MEDICAL RECORD; PHYSICAL ACTIVITY; PREPUBERTY; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; VALIDATION PROCESS;

ADOLESCENT; ADULT; BONE AND BONES; BONE DENSITY; CALCIUM, DIETARY; CHILD; DERMATOMYOSITIS; DRUG THERAPY, COMBINATION; EXERCISE; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS; VASCULITIS;

EID: 17144431337     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Cassidy JT, Langman CB, Allen SH, Hillman LS. Bone mineral metabolism in children with juvenile rheumatoid arthritis. Pediatr Clin North Am 1995;42:1017-33.
2. van Staa TR, Cooper C, Leufkens HG, Bishop N. Children and the risk of fractures caused by oral corticosteroids. Bone Miner Res 2003;18:913-8.
3. Falcini F, Ermini M, Bagnoli F. Bone turnover is reduced in children with juvenile rheumatoid arthritis. J Endocrinol Invest 1998;21:31-6.
4. Varonos S, Ansell BM. Reeve J. Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy. Calcif Tissue Int 1987;41:75-8.
5. Trapani S, Civinini R, Ermini M, Paci E, Falcini F. Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 1998;18:45-9.
6. Castro TC, Terreri MT, Szejnfeld VL, Castro CH, Fisberg M, Gabay M. Bone mineral density in juvenile systemic lupus erythematosus. Braz J Med Biol Res 2002;35:1159-63.
7. Brik R, Keidar Z, Schapira D, Israel O. Bone mineral density and turnover in children with systemic juvenile chronic arthritis. J Rheumatol 1998;25:990-2.
8. Hopp R, Degan J, Gallagher JC, Cassidy JT. Estimation of bone mineral density in children with juvenile rheumatoid arthritis. J Rheumatology 1991;18:1235-9.
9. Falcini F, Trapani S, Civinini R, Capone A, Ermini M, Bartolozzi G. The primary role of steroids on the osteoporosis in juvenile rheumatoid patients evaluated by dual energy X-ray absorptiometry. J Endocrinol Invest 1996;19:165-9.
10. Pepmueller PH, Cassidy JT, Alien SH, Hillman LS. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum 1996;39:746-57.
11. Elsasser U, Wilkins B, Hesp R, Thurnham DI, Reeve J, Ansell BM. Bone rarefaction and crush fractures in juvenile chronic arthritis. Arch Dis Child 1982;57:377-80.
12. Stewart WA, Acott PD, Salisbury SR, Lang BA. Bone mineral density in juvenile dermatomyositis: Assessment using dual x-ray absorptiometry. Arthritis Rheum 2003;48:2294-8.
13. Ferez MD, Abrams SA, Koenning G, Stuff JE, O'Brien KO, Ellis KJ. Mineral metabolism in children with dermatomyositis. J Rheumatol 1994;21:2364-9.
14. Mul D, van Suijlekom-Smit LW, ten Cate R, Bekkering WP, de Muinck Keizer-Schrama SM. Bone mineral density and body composition and influencing factors in children with rheumatic diseases treated with corticosteroids. J Pediatr Endocrinol Metab 2002;15:187-92.
15. Falcini F, Bindi G, Ermini M, et al. Comparison of quantitative calcaneal ultrasound and dual energy X-ray absorptiometry in the evaluation of osteoporotic risk in children with chronic rheumatic diseases. Calcif Tissue Int 2000;67:19-23.
16. Lu PW, Briody JN, Ogle GD, et al. Bone mineral density of total body, spine, and femoral neck in children and young adults: a crosssectional and longitudinal study. J Bone Miner Res 1994;9:1451-8.
17. Wang MC, Aguirre M, Bhudhikanok GS, et al. Bone mass and hip axis length in healthy Asian, Black, Hispanic, and White American youths. J Bone Miner Res 1997;12:1922-35.
18. Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985;28:361-8.
19. Hansen M, Halberg P, Kollerup G, et al. Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment. Scand J Rheumatol 1998;27:197-206.
20. Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 1997;24:1922-9.
21. Pons F, Peris P, Guanabens N, et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-6.
22. Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 2001;28:102-8.
23. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
24. Baker SS, Cochran WJ, Flores CA, et al. American Academy of Pediatrics Committee on Nutrition. Calcium requirements of infants, children, and adolescents. Pediatrics 1999;104:1152-7.
25. Crocker PR, Bailey DA, Faulkner RA, Kowalski KC, McGrath R. Measuring general levels of physical activity: preliminary evidence for the Physical Activity Questionnaire for Older Children. Med Sci Sports Exerc 1997;29:1344-9.
26. Duke PM, Litt IF, Gross RT. Adolescents' self-assessment of sexual maturation. Pediatrics 1980;66:918-20.
27. Tanner JM. Foetus into man: physical growth from conception to maturity. Cambridge, MA: Harvard University Press; 1978:197-9.
28. Johnston CC Jr, Slemenda CW, Melton LJ 3rd. Clinical use of bone densitometry. N Engl J Med 1991;324:1105-9.
29. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporosis Int 1994;4:368-81.
30. Cunnane G, Lane NE. Steroid-induced osteoporosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2000;26:311-29.
31. Swaak AJ, van den Brink HG, Smeenk RJ, Manger K, Kalden JR. Systemic lupus erythematosus: clinical features in patients with disease duration of over 10 years, first evaluation. Rheumatology Oxford 1999;38:953-8.
32. Dhillon VB, Davies MC, Hall ML, et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x-ray absorptiometry. Ann Rheum Dis 1990;49:624-6.
33. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
34. Johnston CC Jr, Miller JZ, Slemenda CW, et al. Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992;327:82-7.
35. Warady BD, Lindsley CB, Robinson FG, Lukert BP. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. J Rheumatol 1994;21:530-5.
36. Reed A, Haugen M, Pachman LM, Langman CB. 25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density. J Pediatr 1991;119:657-60.
37. Morris FL, Naughton GA, Gibbs JL, Carlson JS, Wark JD. Prospective ten-month exercise intervention in premenarcheal girls: positive effects on bone and lean mass. J Bone Miner Res 1997;12:1453-62.
38. Bradney M, Pearce G, Naughton G, et al. Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. J Bone Miner Res 1998;13:1814-21.
39. Mackelvie KJ, McKay HA, Khan KM, Crocker PR. Lifestyle risk factors for osteoporosis in Asian and Caucasian girls. Med Sci Sports Exerc 2001;33:1818-24.
40. Boot AM, De Ridder MA, Pols HA, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density in children and adolescents: Relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab 1997;82:57-62.
41. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
42. Cimaz R, Gattorno M, Sormani MP, et al. Changes in markers of bone turnover and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases. J Rheumatol 2002;29:1786-92.